These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 30532098)

  • 1. Diagnostic Utility of [11C]DTBZ Positron Emission Tomography In Clinically Uncertain Parkinsonism: Experience of a Single Tertiary Center.
    Pérez-Lohman C; Kerik NE; Díaz-Meneses IE; Cervantes-Arriaga A; Rodríguez-Violante M
    Rev Invest Clin; 2018; 70(6):285-290. PubMed ID: 30532098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiating Alzheimer's disease from dementia with Lewy bodies and Parkinson's disease with (+)-[11C]dihydrotetrabenazine positron emission tomography.
    Koeppe RA; Gilman S; Junck L; Wernette K; Frey KA
    Alzheimers Dement; 2008 Jan; 4(1 Suppl 1):S67-76. PubMed ID: 18632004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Potential Positron Emission Tomography Imaging Agent for Vesicular Monoamine Transporter Type 2.
    Huang ZR; Tsai CL; Huang YY; Shiue CY; Tzen KY; Yen RF; Hsin LW
    PLoS One; 2016; 11(9):e0161295. PubMed ID: 27612194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo detection of monoaminergic degeneration in early Parkinson disease by (18)F-9-fluoropropyl-(+)-dihydrotetrabenzazine PET.
    Lin SC; Lin KJ; Hsiao IT; Hsieh CJ; Lin WY; Lu CS; Wey SP; Yen TC; Kung MP; Weng YH
    J Nucl Med; 2014 Jan; 55(1):73-9. PubMed ID: 24287322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tc-99m ethylene cysteinate dimer SPECT in the differential diagnosis of parkinsonism.
    Feigin A; Antonini A; Fukuda M; De Notaris R; Benti R; Pezzoli G; Mentis MJ; Moeller JR; Eidelberg D
    Mov Disord; 2002 Nov; 17(6):1265-70. PubMed ID: 12465066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease.
    Lee CS; Samii A; Sossi V; Ruth TJ; Schulzer M; Holden JE; Wudel J; Pal PK; de la Fuente-Fernandez R; Calne DB; Stoessl AJ
    Ann Neurol; 2000 Apr; 47(4):493-503. PubMed ID: 10762161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic Nigrostriatal Connectivity in Early Parkinson Disease: In Vivo Neuroimaging Study of
    Sanchez-Catasus CA; Bohnen NI; Yeh FC; D'Cruz N; Kanel P; Müller MLTM
    J Nucl Med; 2021 Apr; 62(4):545-552. PubMed ID: 32859707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 11C-DTBZ and 18F-FDG PET measures in differentiating dementias.
    Koeppe RA; Gilman S; Joshi A; Liu S; Little R; Junck L; Heumann M; Frey KA; Albin RL
    J Nucl Med; 2005 Jun; 46(6):936-44. PubMed ID: 15937303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing fludeoxyglucose F18-PET assessment of regional cerebral glucose metabolism and [11C]dihydrotetrabenazine-PET in evaluation of early dementia and mild cognitive impairment.
    Albin RL; Koeppe RA; Burke JF; Giordani B; Kilbourn MR; Gilman S; Frey KA
    Arch Neurol; 2010 Apr; 67(4):440-6. PubMed ID: 20385910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation.
    Adams JR; van Netten H; Schulzer M; Mak E; Mckenzie J; Strongosky A; Sossi V; Ruth TJ; Lee CS; Farrer M; Gasser T; Uitti RJ; Calne DB; Wszolek ZK; Stoessl AJ
    Brain; 2005 Dec; 128(Pt 12):2777-85. PubMed ID: 16081470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Not Available].
    Prange S; Hermier M; Danaila T; Laurencin C; Thobois S
    Presse Med; 2017 Mar; 46(2 Pt 1):202-209. PubMed ID: 28040345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of Parkinson disease severity and 18F-DTBZ positron emission tomography.
    Hsiao IT; Weng YH; Hsieh CJ; Lin WY; Wey SP; Kung MP; Yen TC; Lu CS; Lin KJ
    JAMA Neurol; 2014 Jun; 71(6):758-66. PubMed ID: 24756323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of extrastriatal vesicular monoamine transporter binding site density using stereoisomers of [11C]dihydrotetrabenazine.
    Koeppe RA; Frey KA; Kuhl DE; Kilbourn MR
    J Cereb Blood Flow Metab; 1999 Dec; 19(12):1376-84. PubMed ID: 10598942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discriminating among degenerative parkinsonisms using advanced (123)I-ioflupane SPECT analyses.
    Badoud S; Van De Ville D; Nicastro N; Garibotto V; Burkhard PR; Haller S
    Neuroimage Clin; 2016; 12():234-40. PubMed ID: 27489771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression of dopaminergic depletion in a model of MPTP-induced Parkinsonism in non-human primates. An (18)F-DOPA and (11)C-DTBZ PET study.
    Blesa J; Juri C; Collantes M; Peñuelas I; Prieto E; Iglesias E; Martí-Climent J; Arbizu J; Zubieta JL; Rodríguez-Oroz MC; García-García D; Richter JA; Cavada C; Obeso JA
    Neurobiol Dis; 2010 Jun; 38(3):456-63. PubMed ID: 20304066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dihydrotetrabenazine positron emission tomography imaging in early, untreated Parkinson's disease.
    Martin WR; Wieler M; Stoessl AJ; Schulzer M
    Ann Neurol; 2008 Mar; 63(3):388-94. PubMed ID: 18240153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoaminergic PET imaging and histopathological correlation in unilateral and bilateral 6-hydroxydopamine lesioned rat models of Parkinson's disease: a longitudinal in-vivo study.
    Molinet-Dronda F; Gago B; Quiroga-Varela A; Juri C; Collantes M; Delgado M; Prieto E; Ecay M; Iglesias E; Marín C; Peñuelas I; Obeso JA
    Neurobiol Dis; 2015 May; 77():165-72. PubMed ID: 25681534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative study of
    Jung Lung H; Weng YH; Wen MC; Hsiao IT; Lin KJ
    Sci Rep; 2018 Oct; 8(1):16027. PubMed ID: 30375444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of 11C-PE2I PET in differential diagnosis of parkinsonian disorders.
    Appel L; Jonasson M; Danfors T; Nyholm D; Askmark H; Lubberink M; Sörensen J
    J Nucl Med; 2015 Feb; 56(2):234-42. PubMed ID: 25593112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis.
    Tang CC; Poston KL; Eckert T; Feigin A; Frucht S; Gudesblatt M; Dhawan V; Lesser M; Vonsattel JP; Fahn S; Eidelberg D
    Lancet Neurol; 2010 Feb; 9(2):149-58. PubMed ID: 20061183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.